null - FindTrial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2011-005136-25-FI

Enrollment

Registered

2011-11-10

Start date

2012-01-12

Completion date

Unknown

Last updated

2024-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 14.0 Level: LLT Classification code 10013377 Term: Disorders of uterus, not elsewhere classified System Organ Class: 10038604 - Reproductive system and breast disorders MedDRA version: 14.0 Level: SOC Classification code 10017947 Term: Gastrointestinal disorders System Organ Class: 10017947 - Gastrointestinal disorders

Interventions

Trade Name: Chirocaine 1,25 mg/ml Product Name: Chirocaine 1,25 mgml Pharmaceutical Form: Injection CAS Number: 27262-48-2 Other descriptive name: LEVOBUPIVACAINE HYDROCHLORIDE

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 40 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 40

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Finland

Contacts

Public ContactSponsor

Matti Eskelinen

matti.eskelinen@kuh.fi35817173311

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026